Allogene Therapeutics News - ALLO

Company Name	Stock Ticker Symbol	Market	Type
Allogene Therapeutics Inc	ALLO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.03	-1.19%	2.49	16:33:06

Open Price	Low Price	High Price	Close Price	Prev Close
2.64	2.45	2.66	2.47	2.52

more quote information »

Recent News

Date	Time	Source	Heading
12/09/2023	12:00	GLOBE	Allogene Therapeutics Presents Comprehensive Safety Data of..
12/01/2023	08:30	GLOBE	Allogene Therapeutics Announces Participation in December..
11/03/2023	12:00	GLOBE	Allogene Therapeutics Presents Preclinical Data on Next..
11/02/2023	16:41	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/02/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:03	EDGAR2	Form 8-K - Current report
11/02/2023	16:02	GLOBE	Allogene Therapeutics Reports Third Quarter 2023 Financial..
11/02/2023	09:00	GLOBE	Allogene Therapeutics Announces Poster Presentations at the..
10/30/2023	08:30	GLOBE	Allogene Therapeutics Announces Participation in November..
10/26/2023	08:30	GLOBE	Allogene Therapeutics to Report Third Quarter 2023 Financial..
10/17/2023	16:34	EDGAR2	Form 8-K/A - Current report: [Amend]
10/16/2023	08:31	EDGAR2	Form 8-K - Current report
10/16/2023	08:30	GLOBE	Allogene Therapeutics Appoints Geoffrey Parker as Chief..
9/27/2023	09:09	GLOBE	Allogene Therapeutics Announces Three Poster Presentations..
9/05/2023	08:30	GLOBE	Allogene Therapeutics Announces Participation in September..
8/14/2023	19:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/14/2023	19:28	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/14/2023	08:30	GLOBE	Allogene Therapeutics Appoints Earl Douglas as General..
8/09/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/07/2023	17:15	EDGAR2	Form 144 - Report of proposed sale of securities
8/02/2023	16:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/2023	16:04	EDGAR2	Form 8-K - Current report
8/02/2023	16:02	GLOBE	Allogene Therapeutics Reports Second Quarter 2023 Financial..
7/26/2023	08:30	GLOBE	Allogene Therapeutics to Report Second Quarter 2023..
7/11/2023	06:06	VW	Ethereum Blockchain Game Pikamoon Raises $3.6m, Final ICO..
7/10/2023	10:44	VW	Massive Gaming Celebrates Global Launch of House of..
7/10/2023	05:52	VW	WOW EARN Wallet Offers One-Stop Shop Features, Now Available..
7/10/2023	05:02	VW	Swaap v2 Launches: Revolutionizing DeFi Market Making with..
7/08/2023	10:03	VW	Britanniacoin’s Official Pre-release: introducing a unique..
7/06/2023	11:59	VW	Tether Launches USDt On Kava
7/06/2023	04:03	VW	OKX to Launch Signal Trading Platform, Empowering Traders..
7/05/2023	14:19	VW	Hawkish Fed The Most Likely Reason For A Correction
6/30/2023	06:34	VW	Memecoin MOOKY Raises $900,000 Ahead of Its Final Presale..
6/28/2023	02:32	VW	DWF Labs Doubles Down on Conflux with $28 Million Invested
6/27/2023	08:00	VW	DealHub.io Acquires Usage-based Billing Company Subzee
6/27/2023	02:03	VW	OKX Liquid Marketplace Launches ‘Nitro Spreads’ Enabling..
6/26/2023	09:04	VW	MetaBlaze Announces $4M Crypto Presale Sellout, Gaming..
6/19/2023	11:29	VW	The Top Most-Shorted Stocks Globally
6/15/2023	09:30	GLOBE	Allogene Therapeutics Provides Additional ALLO-501/501A..
6/14/2023	08:00	GLOBE	Allogene Therapeutics Announces Departure of Chief Financial..
6/09/2023	18:25	GLOBE	Allogene Therapeutics Announces Oral Presentation of Phase 1..
6/03/2023	09:00	GLOBE	Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1..
5/24/2023	08:30	GLOBE	Allogene Therapeutics Announces Participation in Three..
5/11/2023	11:50	GLOBE	Allogene Therapeutics Announces Encore Presentation of Phase..
5/03/2023	16:02	GLOBE	Allogene Therapeutics Reports First Quarter 2023 Financial..
4/26/2023	10:06	GLOBE	Allogene Therapeutics Announces Presentation of Phase 1 Data..
4/25/2023	08:30	GLOBE	Allogene Therapeutics to Report First Quarter 2023 Financial..
4/20/2023	16:05	GLOBE	Allogene Therapeutics Appoints Timothy Moore as Chief..
4/17/2023	10:15	GLOBE	Allogene Therapeutics Presents Interim Phase 1 Data on..
4/13/2023	08:30	GLOBE	Allogene Therapeutics Announces Participation in Four..